Author: Lu Han1,2, Jing Wang3,4, Yin Zhu4, Ying Lu1,2, Chaoqun Liu4, Chaoyang Chen1,2, Jie Li4
Affiliation: <sup>1</sup> Shanghai Qigong Research Institute, Shanghai, China.
<sup>2</sup> Taiji Health Center, Shanghai University of T.C.M/Shanghai Academy of T.C.M., Shanghai, China.
<sup>3</sup> Shanghai Baoshan District Hospital of Integrated Traditional and Western Medicine, Shanghai, China.
<sup>4</sup> Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Conference/Journal: Medicine (Baltimore)
Date published: 2024 Jun 28
Other:
Volume ID: 103 , Issue ID: 26 , Pages: e38700 , Special Notes: doi: 10.1097/MD.0000000000038700. , Word Count: 326
This study aims to critically reassess existing systematic reviews (SR) on Traditional Chinese Exercises (TCE) for treating Chronic Obstructive Pulmonary Disease (COPD). The primary objectives include synthesizing available evidence, evaluating the methodological quality of reviews and overall evidence, and providing comprehensive insights into the effectiveness of different TCE types in managing COPD. Sinomed, CNKI, VIP, Wanfang, PubMed, Cochrane Library, and Web of Science were searched from inception to April 2023 for SR literature on the treatment of COPD with TCE. The extracted data from the included SRs encompassed various aspects such as general information, study population, intervention measures, meta-analysis results, and conclusions. The methodological quality of the included SRs was assessed using the AMSTAR II tool. Additionally, the GRADE tool was used to determine the evidence level of outcome indicators. This study included 17 SRs and 4 types of TCE. The CCA was 0.041, indicating a slight overlap between the primary studies. Notably, one study was rated as low quality on the AMSTAR II scale, while the rest were classified as critically low quality. The results from the GRADE evaluation revealed 26 pieces of very low-quality evidence, 55 pieces of low-quality evidence, and 17 pieces of moderate-quality evidence. The moderate-quality evidence suggests that Liuzijue effectively improves TCM syndrome scores in patients with COPD. Additionally, low-quality evidence suggests that Liuzijue improves patients' lung function (FEV1, FVC) and quality of life (CAT, MRC/mMRC). Similarly, low-quality evidence suggests that Baduanjin can improve patients' lung function (FEV1%, FVC) and quality of life (SGRQ). Low-quality evidence also suggests that Health Qigong can significantly improve patients' exercise endurance (6MWD). No SR reported TCE-related adverse reactions. TCE interventions are effective and safe in the treatment of COPD. Different types of TCE have varying effects on outcomes in COPD patients. However, these findings are limited by the generally low methodological and evidence quality of the included SRs. Therefore, it is strongly recommended to improve study designs to obtain higher-quality clinical evidence and to strictly follow SR protocols.
PMID: 38941382 DOI: 10.1097/MD.0000000000038700